This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) advanced 2.01% to $223.43 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&amp;P 500 Index rising 1.97% to 6,932.30 and the Dow Jones Industrial Average rising 2.47% to 50,115.67.
This was the stock's second consecutive day of gains.
AbbVie Inc. closed 8.73% short of its 52-week high of $244.81, which the company reached on October 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson &amp; Johnson (JNJ) rose 0.93% to $239.99, Pfizer Inc. (PFE) rose 2.76% to $27.22, and Amgen Inc. (AMGN) rose 4.49% to $384.32.
Trading volume (6.0 M) remained 431,507 below its 50-day average volume of 6.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 6, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
02-06-26 1632ET

AMGN

AbbVie Inc. (ABBV) shares rose 2.01% to $223.43 on a strong trading day, outperforming some competitors. The S&P 500 Index increased by 1.97%, while the Dow Jones Industrial Average rose by 2.47%. AbbVie is 8.73% below its 52-week high of $244.81. Competitors like Johnson & Johnson, Pfizer, and Amgen also saw gains, with Amgen leading at 4.49%. Trading volume was below the 50-day average.

- AbbVie Inc. (ABBV) shares increased by 2.01% to $223.43, amidst a positive trading session for the stock market.  
- The stock is currently 8.73% below its 52-week high of $244.81, achieved on October 1st, and showed mixed performance compared to competitors like Johnson & Johnson and Pfizer.  
- Trading volume was 6.0 million, falling short of the 50-day average of 6.5 million.

Dow Jones

Amgen

iShares US Pharma

First Trust NYSE Arca Biotech Index Fd

Abbvie

VG Health

Invesco Nasdaq Biotechnology ETF

ALPS Medical Breakthrough

Proshares Ultra Nasdaq Biotech

Health Care Select Sector SPDR

iShares Global Healthcare

S&P 500

VanEck Biotech ETF

Invesco Biotechnology & Genome ETF

Pfizer

Ark Genomic Revolution ETF

Direxion Daily Biotech Top 5 Bull 2X ETF

iShares Biotechnology ETF

Johnson & Johnson

SPDR S&P Biotech

AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day